05/17/2024 4:15 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 8:27 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 8:32 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:55 PM | Vera Therapeutics (Filer)
| Form ARS | |
04/03/2024 4:00 PM | Vera Therapeutics (Filer)
| Form DEF 14A | |
04/03/2024 4:02 PM | Vera Therapeutics (Filer)
| Form DEFA14A | |
|
03/26/2024 7:35 PM | Vera Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:57 PM | Sofinnova Venture Partners X, L.P. (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
03/25/2024 8:46 PM | Katabi Maha (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:54 PM | Katabi Maha (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 6:11 PM | Sofinnova Venture Partners X, L.P. (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/14/2024 3:57 PM | CITADEL ADVISORS LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 2:21 PM | Ares Trading S.A. (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 11:49 AM | Kynam Capital Management, LP (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024 3:45 PM | Longitude Capital Partners IV, LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/01/2024 4:58 PM | Katabi Maha (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:52 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/30/2024 3:54 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 8:58 PM | Vera Therapeutics (Filer)
| Form S-3MEF | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Vera Therapeutics (Subject)
| Form SC 13G | |
01/29/2024 3:27 PM | Lin Celia (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 7:46 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/29/2024 5:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 5:31 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 3:54 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 8:55 PM | COMMODORE CAPITAL LP (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:17 AM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:03 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:15 AM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2024 3:15 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 8:02 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/09/2023 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2023 4:56 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 4:57 PM | Curley Joanne (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 4:59 PM | Lin Celia (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 7:01 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 3:05 PM | COMMODORE CAPITAL LP (Reporting) Vera Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
06/22/2023 3:10 PM | COMMODORE CAPITAL LP (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 6:50 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |